Bandingkan Harga & Kinerja Bakrieland Development Tbk. (ELTY) vs Organon Pharma Indonesia Tbk. (SCPI)
Kinerja harga (24 Jam Terakhir)
Statistik utama
Statistik utama
Perbedaan Bakrieland Development Tbk. dan Organon Pharma Indonesia Tbk.: Bakrieland Development Tbk. diperdagangkan di Rp35 (kapitalisasi pasar 1,52 T, volume 24 jam 58,45 jt), sedangkan Organon Pharma Indonesia Tbk. diperdagangkan di Rp29.000 (kapitalisasi pasar 104,4 M). Perbedaan utamanya: Bakrieland Development Tbk. jauh lebih besar — sekitar 14,6× kapitalisasi pasar Organon Pharma Indonesia Tbk.. Mana yang lebih baik tergantung tujuan investasimu.
| ELTY | SCPI | |
|---|---|---|
Kapitalisasi Pasar | 1,52 T | 104,4 M |
Volume | 58,45 jt | — |
Lot | 584,46 rb | — |
Perputaran | 2,03 M | — |
Harga Rata-rata | 34,68 | — |
Nilai Transaksi | 2,03 M | — |
Harga Ekuilibrium Indikatif | 35 | — |
Volume Ekuilibrium Indikatif | 99,73 rb | — |
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Perbandingan imbal hasil
Imbal hasil berjalan pada periode standar
Berita terkini
Berita terbaru kedua aset
Berita terkini
Berita terbaru kedua aset
Tentang Bakrieland Development Tbk.
PT Bakrieland Development Tbk. (“The Company”) was established with Notarial Deed No. 209 of John Leonard Waworuntu, S.H., dated June 12, 1990. The Company's articles of association have been amended several times, among others, the changes of the Company's name from PT Elang Realty (formerly PT. Purilestari Indah Pratama) Tbk. to PT Bakrieland Development Tbk. which have been notarized by Notarial Deed No. 29 of Harun Kamil, S.H., dated April 3, 1997.
Selengkapnya di halaman ELTY →Tentang Organon Pharma Indonesia Tbk.
PT Merck Sharp Dohme Pharma Tbk was established within the frame work of the Foreign Capital Investment Law No. 1 year 1967 as amended by Law No. 11 year 1970 based on Notarial Deed No. 17 dated 7 March 1972 of Djojo Muljadi, S.H. The company originally incorporated as PT. Essex Indonesia, as a joint venture between Schering Corporation, a worldwide, research-based pharmaceutical enterprise headquartered in the United States, and an Indonesian businessman.
Selengkapnya di halaman SCPI →
